On October 13, 2021, the U.S. Food and Drug Administration (FDA) announced that Azurity Pharmaceuticals Inc. is voluntarily recalling one lot of Firvanq Oral Solution 50 mg/mL Kit as a Class I Recall.

Some products in the affected lot incorrectly contain a First Omeprazole (FIRST-PPI) diluent (diluting agent) instead of the Firvanq diluent bottle.

Please note that not all lots are affected, so you may not be affected by this recall. Only one lot is being recalled. If you are currently taking Firvanq Oral Solution 50 mg/mL, please contact your health care provider to talk about other treatments or medicines that may be appropriate.

For more information, please visit FDA.gov. You can also contact Koral Couch, Senior Manager, Customer Service by phone at 1-781-935-8141 x119 (TTY 711), weekdays, 8:30 a.m. to 5 p.m., or by email. The Horizon NJ Health Pharmacy Help Desk is available at 1-800-682-9094 x81016 (TTY 711), weekdays, 8 a.m. to 5:30 p.m., and Saturday, 8 a.m. to 4:30 p.m.